FDA Inspection 1198206 — Aizant Drug Research Solutions Private Ltd.
The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on January 25, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Clinical BA/BE